| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
49,799 |
14,850 |
$1.23M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
26,210 |
10,409 |
$855K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
38,692 |
7,568 |
$268K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,551 |
5,954 |
$137K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,904 |
1,895 |
$59K |
| 80305 |
|
12,538 |
6,769 |
$40K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
372 |
370 |
$22K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,346 |
930 |
$8K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,601 |
965 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
59 |
59 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
544 |
435 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
93 |
70 |
$358.19 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
166 |
122 |
$60.77 |
| 87807 |
|
35 |
35 |
$39.17 |
| 1159F |
|
30 |
21 |
$0.00 |
| 2010F |
|
51 |
41 |
$0.00 |